To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Ipsen to acquire a portfolio of select consumer healthcare products from Sanofi
- Paula_Isabel_da_Silva_Moreira
- CIS_(Multiple_Sklerose)
- How an Emerging Drug Class Dampens Harmful Immune Reactions - It wasn't until 2021 that a new therapy came on the market, in the form of a class of drugs called compstatins, to inhibit harmful immune responses of the complement system
- Carcinoma_in_situ
